An interventional study of Brief Intervention in Addictions, Adolescents and Primary Health Care, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 15 Years to 25 Years. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by University Hospital, Clermont-Ferrand · Not applicable, Interventional, and Other
How we know · 2 judgments
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 77 studies in Behavior, Addictive with a site in France — 33 open to participants now, 34 under way, none of them phase 3. Behavior, Addictive · France.
Among the 77 studies in Behavior, Addictive with a site in France, this one is the 5th largest by enrollment of the 34 interventional ones that give a count, is one of 2 that started in 2012, is one of 33 with no phase, and was the 6th registered.
522 studies on the registry are indexed under Behavior, Addictive; 125 are open to participants now.
Browse Behavior, Addictive studies →33 of the 77 studies in Behavior, Addictive with a site in France are open now. Recruiting first, the newest first:
Hospices Civils de Lyon · Sites in France
Ages 18+
University of Bordeaux · Sites in France
Ages 18+ · Healthy volunteers
Université de Reims Champagne-Ardenne · Sites in France
Ages 18–65 · Healthy volunteers
University of Bordeaux · Sites in France
Ages 18+
Centre Hospitalier Universitaire de Nīmes · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 81 Behavior, Addictive studies recruiting now, 45 (56%) set no upper age limit and 34 (42%) stop at 75 or younger; 7 take children under 18; 24 take healthy volunteers.
This study: 15 Years to 25 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
77 studies; the count open now beside each. This study's row is marked.
First in 2002; this study’s year is marked. 2 started in 2012.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 261 is above the median of 62 across 399 interventional studies indexed under Behavior, Addictive.
Median enrollment 88 across the 34 interventional studies, 170 across the 43 observational. Of the 31 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 77 has an industry lead sponsor. The 10 most frequent:
University Hospital, Clermont-Ferrand is the lead sponsor of 859 studies on the registry; 177 are open to participants now.
University Hospital, Clermont-Ferrand has 8 studies filed under Behavior, Addictive — fewer than ten, so there is no comparison to draw.
5 of the studies in Behavior, Addictive with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07421765Centre Hospitalier Universitaire de NīmesInteraction Between Atypical Work Schedules and/or Idel Time at Work on At-risk Gambling Practices | 2027-02 |
| NCT05609474Hôpital le VinatierTrajectories and Reactions of Users and Relatives Consulting French Youth Addiction Services | 2027-02-15 |
| NCT07193914Centre Hospitalier Universitaire de NīmesAdaptation of the ECCCLORE Program for Patients With Addictive and Traumatic Problems | 2027-03 |
| NCT07819851Centre Hospitalier Universitaire de NiceA Study of the Correlation Between the Severity of Substance Use Disorder and the Intensity of Dependence on Generative Artificial Intelligence | 2027-06-05 |
| NCT07788352Université de Reims Champagne-Ardennetéléwork and Consumer Behavior: Longitudinal Study | 2027-07-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 77 studies in Behavior, Addictive with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Background: Cannabis is the most prevalent illegal drug used in France, and consequences arising from the step of 'casual consumers'(1-10 joints/month). Side effects of cannabis are now well documented: Trauma (driving after consuming cannabis), respiratory, cardiovascular diseases and psychiatric and social problems. The general practitioner (GP) is the health professional most viewed by adolescents. Brief interventions (BI) for adult alcohol use have been shown to be efficient. Some BI have been designed to inspect adolescents and consumption of cannabis have been piloted, showing their feasibility, but no test has validated them.
Aim : Does a BI conducted by general practitioners reduce consumption of canabis in 15 to 19 years old ?
Method:
Two preliminary qualitative studies (with adolescents and GP), were used to analyze the difficulties of communication around cannabis use. The Scientific Committee has analyzed the results and developed a workshop around BI, adapted to adolescents cannabis users.
CANABIC is a quantitative study to validate use of BI with cannabis users: a randomized controlled trial, clustered study, comparing an intervention group (IG) and a control group (CG). The intervention is the achievement of the IB during a specific consultation. The outcome is the consumption of cannabic (Number of joints / month).
The study will be carried out in 3 french regions : Auvergne, Rhône-Alpes and Languedoc-Roussillon. 150 GPs wil be recruited and randomized in intervention group or control group (ratio 1 :1).
Each GP will inlcude 5 adolescents (i.e. a total of 750 adolescents) - . The number of adolescents needed has been calculate with hypothesis of a significant difference of 30% in consumption of cannabis between adolescents who beneficied of BI (IG) and those who do not experienced BI ( CG) A pilot study has been conducted. Cannabis use by adolescents has decreased. Their perception of cannabis has changed: they are aware of the harmful effects of their consumption. This pilot study has improve many points of the protocol.
Results:
A decrease of 30% of consumption is expected (joints per month). Perception of cannabis by adolescents will be reviewed.
Conclusions:
To validate an IB adaptated to consultation with adolscents cannabis consumer in order to provide a tool for GP in their daily practice.
General organisation of the study
Information to the patient and collection of the patient non opposition (without informing the intervention objectives in the control group).
Evaluation of cannabis consumption, but also tobacco and alcohol consumption. Collection of the perception of cannabis by adolescents, and its impact on health.
Inclusion criteriae : repetead users : 1 to 10 per month; regular users : 11 to 29 per month; daily users : 1 and more per day.
In the IG : achievment of the BI with the adolescent. In each group, making appointment with the patient at 3 months
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
The patient must have given his and signed the form of no objection
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Behavioral: Brief Intervention
Behavioral: Brief Intervention
CANABIC is a quantitative study to validate use of BI with cannabis users: a randomized controlled trial, clustered study, comparing an intervention group (IG) and a control group (CG). The intervention is the achievement of the IB during a specific consultation. The outcome is the consumption of cannabic (Number of joints / month).
the number of joints consumed per month
Time frame: at 12 months
the number of joints consumed per month
Time frame: at 3 and at 6 months
Ran from Mar 2012 to primary completion in Mar 2014, 24 months.
Of 148 non-industry interventional studies with no phase under Behavior, Addictive, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 42. This study's 24 months is below that.
Counting every sponsor, half of 156 studies reached it within 26 months; a quarter within 10 and three quarters within 42.
Completion moved once since we started tracking on Sep 25, 2026: Jul 2014 → Mar 2015, on Nov 9, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand →